Shedding light on the variability of the clinical course of multiple sclerosis: analysis of the influence of myeloidderived suppressor cells on disease severity

被引：0
|
作者：
Ortega, M. C. [1 ]
Garcia-Arocha, J. [1 ]
Lebron-Galan, R. [1 ]
Machin-Diaz, I. [1 ]
Garcia-Alonso, I. [1 ]
Wojtas, B. [2 ]
Nieto-Diaz, M. [3 ]
Camacho-Toledano, C. [1 ]
Serrano-Regal, M. P. [1 ]
Calahorra, L. [1 ]
Kaminska, B. [2 ]
Clemente, D. [1 ]
机构：
[1] Hosp Nacl Paraplej, Neuroimmuno Repair Grp, Toledo, Spain
[2] Nencki Inst Expt Biol, Mol Neurobiol, Warsaw, Poland
[3] Hosp Nacl Paraplej, Mol Neuroprotect Grp, Toledo, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P048
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [1] Myeloid-derived suppressor cells in progressive multiple sclerosis: important factors for clinical course severity
    Ortega, M. C.
    Garcia-Arocha, J.
    Quintanero-Casero, V.
    Lebron-Galan, R.
    Machin-Diaz, I.
    Camacho-Toledano, C.
    Clemente, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 491 - 491
  • [2] Clinical significance of changes of myeloidderived suppressor cells and their subtypes in inflammatory bowel disease
    贺宜
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (03) : 170 - 170
  • [3] Do prodrome symptoms influence multiple sclerosis disease course and severity?
    Vienazindyte, I.
    Cesarskaja, J.
    Vaiciulyte, D.
    Balnyte, R.
    Matijosaitis, V.
    MEDICAL HYPOTHESES, 2022, 165
  • [4] Clinical indexes affecting the course and severity of the disease in multiple sclerosis patients
    Manova, M. G.
    Kostadinova, I. I.
    Trenova, A.
    Zahariev, Z. I.
    Vasileva, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 134 - 135
  • [5] Myeloid-derived suppressor cells as putative biomarker to predict the severity of the clinical course and the potential remyelination in multiple sclerosis
    Ortega, M. C.
    Lebron-Galan, R.
    Perez-Molina, I.
    Garcia-Montero, M. R.
    Machin, I.
    Clemente, D.
    GLIA, 2019, 67 : E538 - E539
  • [6] Peripheral myeloid-derived suppressor cells: a new tool to predict the severity of the clinical course and tissue damage extent in multiple sclerosis
    Lebron-Galan, R.
    Sanchez-de lara, I.
    Nieto-Diaz, M.
    Camacho-Toledano, C.
    Machin-Diaz, I.
    Ortega, M. C.
    Clemente, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 276 - 277
  • [7] Functional shift of myeloid-derived suppressor cells during Multiple Sclerosis disease course
    Iacobaeus, Ellen
    Douagi, Iyadh
    Jitschin, Regina
    Andren, Anton Tornqvist
    Gavin, Caroline
    Lefsihane, Katia
    Davies, Lindsay
    Olsson, Tomas
    Mougiakakos, Dimitrios
    Kadri, Nadir
    Le Blanc, Katarina
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 335 - 335
  • [8] The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
    Melero-Jerez, Carolina
    Alonso-Gomez, Aitana
    Monivas, Esther
    Lebron-Galan, Rafael
    Machin-Diaz, Isabel
    de Castro, Fernando
    Clemente, Diego
    NEUROBIOLOGY OF DISEASE, 2020, 140
  • [9] The Influence of Immunomodulatory Treatment on the Clinical Course of Multiple Sclerosis
    Kavaliunas, Andrius
    Stawiarz, Leszek
    Hedbom, Jonas
    Glaser, Anna
    Hillert, Jan
    GENEDIS 2014: NEURODEGENERATION, 2015, 822 : 19 - 24
  • [10] The influence of immunomodulatory treatment on the clinical course of multiple sclerosis
    Kavaliunas, A.
    Stawiarz, L.
    Glaser, A.
    Hillert, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 192 - 192
12345